| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Antibody development after COVID-19 vaccination in patients with autoimmune diseases in the Netherlands: a substudy of data from two prospective cohort studies
|
Boekel, Laura
|
|
|
3 |
11 |
p. e778-e788
|
artikel
|
| 2 |
Antibody kinetics in patients with rheumatic diseases after SARS-CoV-2 mRNA vaccination
|
Frey, Sarah
|
|
|
3 |
11 |
p. e753-e754
|
artikel
|
| 3 |
B cells: more than just for antibodies in SARS-CoV-2 vaccine responses
|
Paley, Michael A
|
|
|
3 |
11 |
p. e741-e743
|
artikel
|
| 4 |
Bilateral anterior non-necrotising scleritis, anterior uveitis, and unilateral facial nerve palsy in paediatric inflammatory multisystem syndrome temporally associated with COVID-19
|
Islam, Meriam
|
|
|
3 |
11 |
p. e818
|
artikel
|
| 5 |
Composite endpoints for Sjögren's Syndrome
|
Baicus, Cristian
|
|
|
3 |
11 |
p. e751
|
artikel
|
| 6 |
Composite endpoints for Sjögren's Syndrome
|
Yildirim, Derya
|
|
|
3 |
11 |
p. e751-e752
|
artikel
|
| 7 |
Composite endpoints for Sjögren's Syndrome – Authors' reply
|
de Wolff, Liseth
|
|
|
3 |
11 |
p. e752-e753
|
artikel
|
| 8 |
COVID-19: is the rush to boost backed by science?
|
The Lancet Rheumatology,
|
|
|
3 |
11 |
p. e737
|
artikel
|
| 9 |
Current issues in rheumatoid arthritis-associated interstitial lung disease
|
Kelly, Clive
|
|
|
3 |
11 |
p. e798-e807
|
artikel
|
| 10 |
Cutaneous vasculitis following COVID-19 vaccination
|
Cavalli, Giulio
|
|
|
3 |
11 |
p. e743-e744
|
artikel
|
| 11 |
Efficacy of rituximab in patients with polymyalgia rheumatica: a double-blind, randomised, placebo-controlled, proof-of-concept trial
|
Marsman, Diane E
|
|
|
3 |
11 |
p. e758-e766
|
artikel
|
| 12 |
Encouraging data on rituximab in polymyalgia rheumatica
|
Sandovici, Maria
|
|
|
3 |
11 |
p. e738-e739
|
artikel
|
| 13 |
FDA expands JAK inhibitors warning: going beyond the data?
|
Thorley, Jennifer
|
|
|
3 |
11 |
p. e757
|
artikel
|
| 14 |
Haemophagocytic lymphohistiocytosis secondary to COVID-19: a case series
|
Flower, Luke
|
|
|
3 |
11 |
p. e744-e747
|
artikel
|
| 15 |
Humoral and cellular responses to mRNA vaccines against SARS-CoV-2 in patients with a history of CD20 B-cell-depleting therapy (RituxiVac): an investigator-initiated, single-centre, open-label study
|
Moor, Matthias B
|
|
|
3 |
11 |
p. e789-e797
|
artikel
|
| 16 |
Immunocompromised patients in the USA and UK should receive third dose of COVID-19 vaccine
|
Furlow, Bryant
|
|
|
3 |
11 |
p. e756
|
artikel
|
| 17 |
Inflammatory myositis after ChAdOx1 vaccination
|
Maramattom, Boby Varkey
|
|
|
3 |
11 |
p. e747-e749
|
artikel
|
| 18 |
Precision medicine in juvenile idiopathic arthritis—has the time arrived?
|
Reiff, Daniel D
|
|
|
3 |
11 |
p. e808-e817
|
artikel
|
| 19 |
Research in Brief
|
Thorley, Jennifer
|
|
|
3 |
11 |
p. e755
|
artikel
|
| 20 |
Surgical microdiscectomy versus transforaminal epidural steroid injection in patients with sciatica due to lumbar disc herniation
|
Tiwari, Vivek
|
|
|
3 |
11 |
p. e750
|
artikel
|
| 21 |
Surgical microdiscectomy versus transforaminal epidural steroid injection in patients with sciatica due to lumbar disc herniation – Authors' reply
|
Wilby, Martin John
|
|
|
3 |
11 |
p. e750-e751
|
artikel
|
| 22 |
Tapering and withdrawal in patients with rheumatoid arthritis in stable remission
|
Hill, Catherine L
|
|
|
3 |
11 |
p. e739-e741
|
artikel
|
| 23 |
Treatment tapering and stopping in patients with rheumatoid arthritis in stable remission (RETRO): a multicentre, randomised, controlled, open-label, phase 3 trial
|
Tascilar, Koray
|
|
|
3 |
11 |
p. e767-e777
|
artikel
|
Tijdschrift beschrijving